Dr. Sirisha Donekal, MD

Dr. Donekal practices at University of Maryland Baltimore Washington Medical Center in Glen Burnie, Maryland, part of University of Maryland Medical System.

Dr. Donekal's NPI, 1386826824, was assigned on November 27, 2007. Dr. Donekal holds Maryland license D0069545.

Dr. Donekal's primary practice is University of Maryland Baltimore Washington Medical Center, at 301 Hospital Drive, Glen Burnie, MD 21061 in Anne Arundel County. The practice phone is (410) 595-1967.

Dr. Donekal's primary practice is University of Maryland Baltimore Washington Medical Center in Glen Burnie, Maryland, part of University of Maryland Medical System. The medical group on file is UM Community Medical Group. Dmand AI also links Dr. Donekal to 1 more physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Donekal practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Donekal's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Donekal is licensed in Maryland.

CMS data shows 1,500 Medicare services from Dr. Donekal across 11 procedure codes in 2024, for 322 Medicare patients. Medicare paid $178,644 for them. Every service was in an office.

CMS counts 322 Medicare patients who saw Dr. Donekal in 2024. The largest group is 65 to 74, with 145 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Donekal's median patient age at 67, with 54% women.

In 2024, Dr. Donekal wrote 1,189 Medicare Part D claims for 257 patients. 83% of them were for generic drugs. CMS names the drug for 1,013 of them, across 19 drugs with 11 or more claims each, at $128,830 in total drug cost. In 2023, CMS named 918 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Donekal for performance year 2024, reported individually. Dr. Donekal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 23 general payments to Dr. Donekal from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $99.